Search research articles
Contact Us
Filters
Showing results (91-100 of 453) with videos related to
Page
of 46
Sort By:
JAMA Neurology
|
July 16, 2014
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply
Joanna Kitley, Patrick Waters, Angela Vincent, et al.
Clinical Biochemistry
|
November 28, 2016
Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies
Matteo Gastaldi, Anaïs Thouin, Diego Franciotta, et al.
Muscle & Nerve
|
December 26, 2001
The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction
Yohan Liyanage, Werner Hoch, David Beeson, et al.
BMJ (Clinical Research Ed.)
|
April 23, 2011
Autoimmune encephalitis
Sarosh R Irani, Angela Vincent, Jonathan M Schott
Epilepsia
|
November 9, 2010
Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission
Tatjana Lalic, Philippa Pettingill, Angela Vincent, et al.
Journal of Neuroimmunology
|
April 19, 2005
Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation
Ian Spreadbury, Uday Kishore, David Beeson, et al.
The Neurologist
|
May 5, 2017
Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity
Thashi Chang, Patrick Waters, Mark Woodhall, et al.
Molecular & Cellular Proteomics : MCP
|
April 1, 2009
Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies
Edward Littleton, Mathias Dreger, Jackie Palace, et al.
Frontiers in Immunology
|
December 20, 2024
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
Omar Keritam, Angela Vincent, Fritz Zimprich, et al.
The Lancet. Neurology
|
July 10, 2003
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets
Angela Vincent, John Bowen, John Newsom-Davis, et al.
Page
of 46
Search research articles
Search
Showing results (91-100 of 453) with videos related to
Sort By:
Page
of 46
JAMA Neurology
|
July 16, 2014
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply
Joanna Kitley, Patrick Waters, Angela Vincent, et al.
Clinical Biochemistry
|
November 28, 2016
Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies
Matteo Gastaldi, Anaïs Thouin, Diego Franciotta, et al.
Muscle & Nerve
|
December 26, 2001
The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction
Yohan Liyanage, Werner Hoch, David Beeson, et al.
BMJ (Clinical Research Ed.)
|
April 23, 2011
Autoimmune encephalitis
Sarosh R Irani, Angela Vincent, Jonathan M Schott
Epilepsia
|
November 9, 2010
Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission
Tatjana Lalic, Philippa Pettingill, Angela Vincent, et al.
Journal of Neuroimmunology
|
April 19, 2005
Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation
Ian Spreadbury, Uday Kishore, David Beeson, et al.
The Neurologist
|
May 5, 2017
Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity
Thashi Chang, Patrick Waters, Mark Woodhall, et al.
Molecular & Cellular Proteomics : MCP
|
April 1, 2009
Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies
Edward Littleton, Mathias Dreger, Jackie Palace, et al.
Frontiers in Immunology
|
December 20, 2024
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
Omar Keritam, Angela Vincent, Fritz Zimprich, et al.
The Lancet. Neurology
|
July 10, 2003
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets
Angela Vincent, John Bowen, John Newsom-Davis, et al.
Page
of 46